
European Journal of Medicinal Chemistry p. 619 - 622 (1989)
Update date:2022-08-03
Topics:
Chapleo, Christopher B.
Doxey, John C.
Myers, Peter L.
Myers, Malcolm
Smith, Colin F. C.
Stillings, Michael R.
A preliminary communication reported on the pharmacology of the potent partial α2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central α2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard α-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in α-affinity. - α2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives
View MoreContact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Contact:0086-27-83607103/83642615
Address:No.498, Jianshe Ave, Wuhan, China
Jinan Boss Chemical Industry Co., Ltd.【revoke the business license】
website:http://www.chemboss.com.cn
Contact:+86-531-58591595
Address:No2.Hualong Road, Jinan, China
HANGZHOU TOYOND BIOTECH CO., LTD
Contact:+86-571-86965177
Address:No. 189, Fengqi East Road, Hangzhou, China
website:http://www.eastarchem.com/
Contact:1-800-898-2436
Address:1215 K Street, STE 1700
Doi:10.1021/jo00981a018
(1972)Doi:10.1039/c29710001496
(1971)Doi:10.1248/cpb.49.525
(2001)Doi:10.1007/BF00477394
()Doi:10.1021/acs.joc.5b01618
(2015)Doi:10.1016/S0960-894X(01)00776-4
(2002)